Tracking Industry’s Lawsuits Against IRA’s Medicare Price Negotiations

 
• By Jessica Merrill, Scrip Team, and Nancy Pham

Industry stakeholders have filed various lawsuits against the US government, attempting to slow down or block the implementation of a new Medicare drug price negotiation program. Scrip's new chart tracks the developments.

US Federal Courthouse
Multiple pharma companies have filed suits against the Medicare drug price negotiation law. • Source: Shutterstock

More from Drug Pricing

More from Scrip